Intrathecal opioid therapy for pain

Efficacy and outcomes

Wolfhard Winkelmuller, Kim Burchiel, Jean Pierre Van Buyten

Research output: Contribution to journalArticle

15 Citations (Scopus)

Abstract

Although opioid therapy has been accepted for the treatment of patients with cancer pain, its use for nonmalignant pain is still regarded as controversial due to concerns about the development of tolerance and psychological dependence. However, recent studies indicate that there is a low incidence of addiction in patients who do not have a history of addictive disorders, and opioid use is increasing for long-term treatment in patients with nonmalignant pain. This paper reviews the results from recent studies that evaluated the efficacy of intrathecal opioid delivery using a number of outcome measures. These studies demonstrate that intrathecal opioid delivery produces short-term relief of specific symptoms and improves long-term outcomes such as patient functioning (measured by increases in activities of daily living [ADLs] and capacity to work), mood, treatment satisfaction, and quality of life, as well as decreases in oral opioid use. Furthermore, these studies showed there was no development of tolerance or addiction in patients who received long-term intrathecal opioid delivery.

Original languageEnglish (US)
Pages (from-to)67-76
Number of pages10
JournalNeuromodulation
Volume2
Issue number2
DOIs
StatePublished - 1999

Fingerprint

Opioid Analgesics
Pain
Therapeutics
Activities of Daily Living
Quality of Life
Outcome Assessment (Health Care)
Psychology
Incidence

Keywords

  • Cancer pain
  • Intraspinal
  • Intrathecal
  • Morphine
  • Nonmalignant pain
  • Opioid

ASJC Scopus subject areas

  • Anesthesiology and Pain Medicine
  • Neuroscience(all)

Cite this

Intrathecal opioid therapy for pain : Efficacy and outcomes. / Winkelmuller, Wolfhard; Burchiel, Kim; Van Buyten, Jean Pierre.

In: Neuromodulation, Vol. 2, No. 2, 1999, p. 67-76.

Research output: Contribution to journalArticle

Winkelmuller, Wolfhard ; Burchiel, Kim ; Van Buyten, Jean Pierre. / Intrathecal opioid therapy for pain : Efficacy and outcomes. In: Neuromodulation. 1999 ; Vol. 2, No. 2. pp. 67-76.
@article{cfb451910dd146fea42eac358b0b5302,
title = "Intrathecal opioid therapy for pain: Efficacy and outcomes",
abstract = "Although opioid therapy has been accepted for the treatment of patients with cancer pain, its use for nonmalignant pain is still regarded as controversial due to concerns about the development of tolerance and psychological dependence. However, recent studies indicate that there is a low incidence of addiction in patients who do not have a history of addictive disorders, and opioid use is increasing for long-term treatment in patients with nonmalignant pain. This paper reviews the results from recent studies that evaluated the efficacy of intrathecal opioid delivery using a number of outcome measures. These studies demonstrate that intrathecal opioid delivery produces short-term relief of specific symptoms and improves long-term outcomes such as patient functioning (measured by increases in activities of daily living [ADLs] and capacity to work), mood, treatment satisfaction, and quality of life, as well as decreases in oral opioid use. Furthermore, these studies showed there was no development of tolerance or addiction in patients who received long-term intrathecal opioid delivery.",
keywords = "Cancer pain, Intraspinal, Intrathecal, Morphine, Nonmalignant pain, Opioid",
author = "Wolfhard Winkelmuller and Kim Burchiel and {Van Buyten}, {Jean Pierre}",
year = "1999",
doi = "10.1046/j.1525-1403.1999.00067.x",
language = "English (US)",
volume = "2",
pages = "67--76",
journal = "Neuromodulation",
issn = "1094-7159",
publisher = "Wiley-Blackwell",
number = "2",

}

TY - JOUR

T1 - Intrathecal opioid therapy for pain

T2 - Efficacy and outcomes

AU - Winkelmuller, Wolfhard

AU - Burchiel, Kim

AU - Van Buyten, Jean Pierre

PY - 1999

Y1 - 1999

N2 - Although opioid therapy has been accepted for the treatment of patients with cancer pain, its use for nonmalignant pain is still regarded as controversial due to concerns about the development of tolerance and psychological dependence. However, recent studies indicate that there is a low incidence of addiction in patients who do not have a history of addictive disorders, and opioid use is increasing for long-term treatment in patients with nonmalignant pain. This paper reviews the results from recent studies that evaluated the efficacy of intrathecal opioid delivery using a number of outcome measures. These studies demonstrate that intrathecal opioid delivery produces short-term relief of specific symptoms and improves long-term outcomes such as patient functioning (measured by increases in activities of daily living [ADLs] and capacity to work), mood, treatment satisfaction, and quality of life, as well as decreases in oral opioid use. Furthermore, these studies showed there was no development of tolerance or addiction in patients who received long-term intrathecal opioid delivery.

AB - Although opioid therapy has been accepted for the treatment of patients with cancer pain, its use for nonmalignant pain is still regarded as controversial due to concerns about the development of tolerance and psychological dependence. However, recent studies indicate that there is a low incidence of addiction in patients who do not have a history of addictive disorders, and opioid use is increasing for long-term treatment in patients with nonmalignant pain. This paper reviews the results from recent studies that evaluated the efficacy of intrathecal opioid delivery using a number of outcome measures. These studies demonstrate that intrathecal opioid delivery produces short-term relief of specific symptoms and improves long-term outcomes such as patient functioning (measured by increases in activities of daily living [ADLs] and capacity to work), mood, treatment satisfaction, and quality of life, as well as decreases in oral opioid use. Furthermore, these studies showed there was no development of tolerance or addiction in patients who received long-term intrathecal opioid delivery.

KW - Cancer pain

KW - Intraspinal

KW - Intrathecal

KW - Morphine

KW - Nonmalignant pain

KW - Opioid

UR - http://www.scopus.com/inward/record.url?scp=0032997375&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0032997375&partnerID=8YFLogxK

U2 - 10.1046/j.1525-1403.1999.00067.x

DO - 10.1046/j.1525-1403.1999.00067.x

M3 - Article

VL - 2

SP - 67

EP - 76

JO - Neuromodulation

JF - Neuromodulation

SN - 1094-7159

IS - 2

ER -